Davis Rea’s Elevance Health ELV Stock Holding History

Davis Rea’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,200	Closed	-$339K	–	52
2019 Q2	$339K	Hold	1,200	–	–	0.2%	53
2019 Q1	$344K	Hold	1,200	–	–	0.2%	49
2018 Q4	$315K	Hold	1,200	–	–	0.21%	46
2018 Q3	$329K	Hold	1,200	–	–	0.19%	43
2018 Q2	$286K	Hold	1,200	–	–	0.19%	41
2018 Q1	$264K	Hold	1,200	–	–	0.17%	44
2017 Q4	$270K	Hold	1,200	–	–	0.15%	43
2017 Q3	$228K	Sell	1,200 -100	-8%	-$19K	0.13%	40
2017 Q2	$245K	Hold	1,300	–	–	0.16%	38
2017 Q1	$215K	Buy	+1,300	New	+$207K	0.14%	37
2015 Q3	–	Sell	-1,300	Closed	-$213K	–	42
2015 Q2	$213K	Hold	1,300	–	–	0.13%	40
2015 Q1	$201K	Buy	+1,300	New	+$185K	0.13%	42

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Davis Rea's ELV Position: Q3 2019 in Review

Davis Rea sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 1,200 shares — an estimated $339K sold.

Davis Rea first reported a position in ELV in Q1 2015 and held it in 12 quarters. The position peaked at $344K in Q1 2019. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Davis Rea reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
Davis Rea sold 1,200 Elevance Health shares in Q3 2019, an estimated $339K.
Davis Rea first reported a position in Elevance Health in Q1 2015 and held it in 12 quarters.
Davis Rea's Elevance Health position peaked at $344K in Q1 2019.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Davis Rea's 13F filing for Q3 2019, filed 29 Oct 2019.